Warning (512): /home/pharma/website/current/cakephp/app/pharmalicensing/tmp/cache/ is not writable [CORE/cake/libs/cache/file.php, line 267]
A one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Subscribe now for instant access to the benefits Pharmalicensing Intelligence has to offer.
Our Industry news section provides you with up to date news at your fingertips; searchable by keyword, category and therapeutic target.
News items are linked to company profiles, where relevant.
Visit the Industry news section for a preview of the most recent news.
Our Deals review gathers deal information into one place, saving you time and money by gathering industry intelligence and providing data to help you to benchmark your deals.
Deals data is linked to company profiles, where relevant.
See the Deals review section for a preview of deals headlines.
With an international audience of over 190,000 visitors each month, Innovaro Pharmalicensing is the perfect place to publish your press releases.
A Pharmalicensing Intelligence subscription allows you to submit an unlimited number of press releases via a simple form*.
Browse the Press releases section for a preview of the most recent submissions.
Your personalised Pharmalicensing Intelligence homepage gathers all of the elements of your subscription in one place and can be tailored to your requirements by selecting up to 3 categories that are of specific interest to you. Once you have chosen your categories your homepage will display the latest information according to the filters you have applied.
For example, if you select 'oncology' your homepage will display oncology related reports, oncology related press releases etc.
Your filters can easily be changed or removed for ultimate flexibility.
For more information please contact us on: +44 1904 520 460 or to buy online please select your subscription below:
Single user
$1,500
3 user
$2,950
10 user
$6,400
The subscription period is 12 months. Above costs apply to Pharmabiotech and academic groups. Consultancy, marketing, financial and PR Companies should contact our team for further information.
Articles - Ever wanted to get an article published? With a Pharmalicensing Intelligence subscription your opinions could be broadcast to our audience of over 190,000 unique visitors each month in our Articles section.
Client Care support - At Innovaro Pharmalicensing we are committed to ensuring our clients reap the utmost benefit from our services. That is why our Client Care team are close-at-hand to offer help and guidance throughout your subscription. This is why our Client Care team are readily available to offer any help and guidance which you may require.
Unlocking Information - A Pharmalicensing Intelligence subscription unlocks additional information on company profiles, where available.
* Subject to review by our editorial team, for more information see Terms and Conditions.
Covering a magnitude of biopharmaceutical topics from licensing processes to management strategies and therapeutic overviews; the Innovaro Pharmalicensing Biopharma Reports Store offers a diverse collection of biopharma and pharmaceutical reports to support and improve your life science decisions.
A Pharmalicensing Intelligence subscription entitles you to an amazing 10% discount on all reports purchased through the store.
Our reports store is fully searchable by category, keyword and publisher to direct you to the report that matches your requirements.
Visit the Innovaro Pharmalicensing Biopharma Reports Store and see what benefits the Pharmalicensing Intelligence discount can deliver.
| Nr | Query | Error | Affected | Num. rows | Took (ms) |
|---|---|---|---|---|---|
| 1 | DESCRIBE `dms_releases` | 10 | 10 | 3 | |
| 2 | DESCRIBE `dms_categories` | 4 | 4 | 1 | |
| 3 | DESCRIBE `dms_clinical_areas` | 4 | 4 | 1 | |
| 4 | DESCRIBE `dms_categories_dms_releases` | 2 | 2 | 1 | |
| 5 | DESCRIBE `dms_clinical_areas_dms_releases` | 2 | 2 | 1 | |
| 6 | DESCRIBE `dms_releases_sites` | 5 | 5 | 16 | |
| 7 | DESCRIBE `category` | 14 | 14 | 1 | |
| 8 | DESCRIBE `categories_sites` | 5 | 5 | 1 | |
| 9 | DESCRIBE `story` | 12 | 12 | 3 | |
| 10 | DESCRIBE `categorisation` | 8 | 8 | 1 | |
| 11 | DESCRIBE `sites_stories` | 5 | 5 | 2 | |
| 12 | DESCRIBE `licopp` | 23 | 23 | 2 | |
| 13 | DESCRIBE `company` | 27 | 27 | 1 | |
| 14 | DESCRIBE `condet` | 17 | 17 | 2 | |
| 15 | DESCRIBE `countrycode` | 4 | 4 | 3 | |
| 16 | DESCRIBE `person` | 15 | 15 | 11 | |
| 17 | DESCRIBE `account` | 29 | 29 | 6 | |
| 18 | DESCRIBE `product_legacy` | 6 | 6 | 2 | |
| 19 | DESCRIBE `sales_people` | 6 | 6 | 4 | |
| 20 | DESCRIBE `profile` | 14 | 14 | 3 | |
| 21 | DESCRIBE `currencies` | 7 | 7 | 2 | |
| 22 | DESCRIBE `update_rec` | 7 | 7 | 11 | |
| 23 | DESCRIBE `user` | 24 | 24 | 62 | |
| 24 | DESCRIBE `enquiry` | 14 | 14 | 33 | |
| 25 | DESCRIBE `module_types` | 6 | 6 | 2 | |
| 26 | DESCRIBE `dms_companies` | 26 | 26 | 31 | |
| 27 | DESCRIBE `development_statuses` | 5 | 5 | 15 | |
| 28 | DESCRIBE `licopps_sites` | 3 | 3 | 3 | |
| 29 | DESCRIBE `service` | 15 | 15 | 28 | |
| 30 | DESCRIBE `press_release` | 13 | 13 | 22 | |
| 31 | DESCRIBE `press_releases_sites` | 5 | 5 | 17 | |
| 32 | DESCRIBE `story_assoc` | 4 | 4 | 5 | |
| 33 | DESCRIBE `companies_sites` | 3 | 3 | 3 | |
| 34 | DESCRIBE `categories_users` | 2 | 2 | 3 | |
| 35 | DESCRIBE `authority` | 3 | 3 | 13 | |
| 36 | DESCRIBE `sites_users` | 5 | 5 | 10 | |
| 37 | DESCRIBE `feature_article` | 13 | 13 | 4 | |
| 38 | DESCRIBE `feature_author` | 13 | 13 | 1 | |
| 39 | DESCRIBE `newsml` | 9 | 9 | 2 | |
| 40 | DESCRIBE `prnsubjects` | 4 | 4 | 4 | |
| 41 | DESCRIBE `newsml_prnsubjects` | 2 | 2 | 1 | |
| 42 | DESCRIBE `sites` | 5 | 5 | 1 | |
| 43 | SELECT `Site`.`id`, `Site`.`name`, `Site`.`email_domain`, `Site`.`short_name`, `Site`.`brand` FROM `sites` AS `Site` WHERE `Site`.`id` = 1 LIMIT 1 | 1 | 1 | 1 |